Mosley, S. A., Kim, S., El Rouby, N., Lingineni, K., Esteban, V. V., Gong, Y., Chen, Y., Estores, D., Feng, K., Kim, H., Kinjo, M., Langaee, T., Li, Z., Schmidt, S. O. F., Johnson, J. A., Frye, R. F., Fang, L., Zhao, L., Binkley, P. F., Schmidt, S., & Cavallari, L. H. (2022). a randomized, cross‐over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. Clinical and translational science, 15(7), 1764–1775. http://access.bl.uk/ark:/81055/vdc_100159488075.0x000017